Home > Income Statement > VAISHALI PHARMA

VAISHALI PHARMA
Revenue

    Back to Income Statement
VAISHALI PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

VAISHALI PHARMA Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹99 Cr₹86 Cr₹70 Cr₹76 Cr₹54 Cr

What is the latest Revenue of VAISHALI PHARMA ?

The latest Revenue ratio of VAISHALI PHARMA is ₹99 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹99 Cr
Mar2024₹86 Cr
Mar2023₹70 Cr
Mar2022₹76 Cr
Mar2021₹54 Cr

How is Revenue of VAISHALI PHARMA Trending?

Years Revenue % Change
Mar2025 ₹99 Cr
14.77
Mar2024 ₹86 Cr
23.85
Mar2023 ₹70 Cr
-8.12
Mar2022 ₹76 Cr
41.00
Mar2021 ₹54 Cr -

Compare Revenue of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹78.0 Cr -0.2% -23.8% -52.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,470.0 Cr -0.3% 3.1% 2.2% Stock Analytics
DIVIS LABORATORIES ₹161,996.0 Cr 0.5% -2.9% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,440.0 Cr 0.1% 1.4% 37.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,417.0 Cr 1.9% 1.4% 10.7% Stock Analytics
CIPLA ₹101,445.0 Cr -3.3% -6.9% -17% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-0.2%

-23.8%

-52.3%

SENSEX

-0%

-10.7%

1%


You may also like the below Video Courses